Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | HTT | P42858 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | GLA | P06280 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
| ▸ | MPI | P34949 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9750447 | 0.80 | PGR (0.33) | ALDH1A1TDP1LMNAMAPTRECQL | |
| SCHEMBL4601894 | 0.78 | MPI (0.32) | ALDH1A1TDP1KDM4EMPI | |
| SCHEMBL6521299 | 0.78 | POLB (0.44) | MEN1ALDH1A1POLBKMT2AKDM4E | |
| SCHEMBL9750187 | 0.77 | PDK2 (0.42) | MEN1ALDH1A1KMT2ATDP1LMNA | |
| SCHEMBL9750256 | 0.77 | ALDH1A1 (0.35) | MEN1ALDH1A1POLBKMT2ALMNA | |
| SCHEMBL10938890 | 0.77 | GABRA1 (0.34) | ALDH1A1TDP1LMNAMPI | |
| SCHEMBL11019010 | 0.76 | HTR2A (0.33) | — | |
| SCHEMBL4602669 | 0.74 | MPI (0.38) | MEN1KMT2ATDP1HTTKDM4E | |
| SCHEMBL9750191 | 0.74 | PDK2 (0.39) | MEN1ALDH1A1POLBKMT2ATDP1 | |
| SCHEMBL9750451 | 0.72 | ALDH1A1 (0.44) | MEN1ALDH1A1KMT2ATDP1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1194633-B1 | AGENT FOR COLORING FIBERS AND METHOD FOR TEMPORARILY COLORING FIBERS | WELLA AG (DE) | 2008-04-30 | — | — | EP | claimed |
| EP-1341503-B1 | AGENT AND METHOD FOR DYEING KERATIN FIBRES | WELLA AG (DE) | 2008-02-13 | — | — | EP | claimed |
| EP-1227786-B1 | AGENT FOR DYEING FIBRES COMPRISING AN INDOLINE/INDOLIUM DERIVATIVE | WELLA AG (DE) | 2005-08-24 | — | — | EP | claimed |
| US-6835212-B2 | Compound with a nucleophilic reaction center, aryl alcohol or benzyl alcohol derivatives and an oxidizing enzyme | WELLA AKTIENGESELLSCHAFT (DE) | 2004-12-28 | — | — | US | claimed |
| EP-1194118-B1 | AGENT FOR COLORING FIBERS | WELLA AG (DE) | 2004-09-15 | — | — | EP | claimed |
| US-6740128-B2 | BLEND CONTAINING ENAMINE AND ALKALINE MIXTURE OF ALDEHYDE AND PRIMARY AMINE | WELLA AKTIENGESELLSCHAFT (DE) | 2004-05-25 | — | — | US | claimed |
| US-6669739-B2 | Agent for coloring fibers and method for temporarily coloring fibers | WELLA AKTIENGESELLSCHAFT (DE) | 2003-12-30 | — | — | US | claimed |
| US-6652601-B2 | For dyeing and subsequently decolorizing fibers such as keratin fibers | WELLA AKTIENGESELLSCHAFT (DE) | 2003-11-25 | — | — | US | claimed |
| US-20030101520-A1 | Agent for coloring fibers | WELLA INTERNATIONAL OPERATIONS SWITZERLAND SARL (CH) | 2003-06-05 | — | — | US | claimed |
| US-20030079301-A1 | Agent for dyeing fibers comprising an indoline/indolium derivative | WELLA INTERNATIONAL OPERATIONS SWITZERLAND SARL (CH) | 2003-05-01 | — | — | US | claimed |
| US-20030041391-A1 | Agent and method for dyeing keratin fibres | Wella GmbH (DE) | 2003-03-06 | — | — | US | claimed |
| US-20020172651-A1 | Agent for coloring fibers and method for temporarily coloring fibers | WELLA INTERNATIONAL OPERATIONS SWITZERLAND SARL (CH) | 2002-11-21 | — | — | US | claimed |
| EP-1194633-A1 | AGENT FOR COLORING FIBERS AND METHOD FOR TEMPORARILY COLORING FIBERS | Wella Aktiengesellschaft (DE) | 2002-04-10 | — | — | EP | claimed |
| WO-2001086057-A1 | AGENT FOR COLORING FIBERS AND METHOD FOR TEMPORARILY COLORING FIBERS | WELLA AKTIENGESELLSCHAFT (DE) | 2001-11-15 | — | — | WO | claimed |
| EP-1194633-B1 | AGENT FOR COLORING FIBERS AND METHOD FOR TEMPORARILY COLORING FIBERS | WELLA AG (DE) | 2008-04-30 | — | — | EP | disclosed |
| EP-1699427-B1 | AGENT AND METHOD FOR OXIDATIVELY DYING KERATIN FIBERS | WELLA AG (DE) | 2008-02-27 | — | — | EP | disclosed |
| EP-1341503-B1 | AGENT AND METHOD FOR DYEING KERATIN FIBRES | WELLA AG (DE) | 2008-02-13 | — | — | EP | disclosed |
| US-4201707-A | Methine dyestuffs containing a phenyl azo group | BAYER AKTIENGESELLSCHAFT (DE) | 1980-05-06 | — | — | US | disclosed |
| US-4143228-A | RED SHADES | BAYER AKTIENGESELLSCHAFT (DE) | 1979-03-06 | — | — | US | disclosed |
| US-4138570-A | METHINE DYE | BAYER AKTIENGESELLSCHAFT (DE) | 1979-02-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030079301-A1 | Agent for dyeing fibers comprising an indoline/indolium derivative | IDO1, IDO2, KIT | MEN1 1860/4885ALDH1A1 25/4885POLB 1697/4885 |
| US-20030101520-A1 | Agent for coloring fibers | COL1A1, ENO1, H1-5 | MEN1 996/4885ALDH1A1 6/4885POLB 770/4885 |
| US-20020172651-A1 | Agent for coloring fibers and method for temporarily coloring fibers | ENO1, H1-5, H1-2 | MEN1 1144/4885ALDH1A1 62/4885POLB 1669/4885 |
| US-20030041391-A1 | Agent and method for dyeing keratin fibres | KRT18, AKR7A2, ADH5 | MEN1 4837/4885ALDH1A1 27/4885POLB 492/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.